Shanghai: Reckitt Benckiser Group Plc, which imports more than two-fifths of the products it sells in the United States, is aiming to boost production in America amid the threat of tariffs under incoming President Donald Trump.
The company’s share of imports could fall to 25% when an over-the-counter factory in North Carolina begins making Mucinex tablets and liquids in 2027, the consumer-product maker said in a statement.
